This is a cluster season, again

April 12, 2019

Cluster headaches derive their name from the fact that they occur daily for a period of one to several months. It is rarely noted that these cluster periods occur in many patients at the same time. We do not see any cluster patients for several months and then, we see them daily for a couple of months and now is such a period. It is not clear what environmental factors may be playing a role. These periods when cluster patients start having their attacks do not appear to be related to barometric pressure changes, high allergy seasons, pollution, or any other factors. In some patients attacks occur always in the same season and even the same month, but in many a cluster period can start at any time.

Cluster headaches often cause extremely severe pain, which is always on one side and rarely switch sides from one cluster period to the next. The pain is accompanied by nasal congestion, runny nose and tearing on the side of the headache. Unlike migraine patients who prefer to lie down in a dark and quiet place and not move, patients with cluster headaches become agitated and cannot sit still. The attacks occur once or several times a day, often at the same time of day or night and last anywhere from 15 minutes to a couple of hours. Cluster headaches occur at least twice as often in men than in women and this is probably why cluster headaches are often misdiagnosed in women.

A recent review confirmed that cluster headaches respond well to inhalation of oxygen. The only FDA-approved treatment for the treatment of cluster headaches is injection of sumatriptan to treat each attack. To stop the entire cluster we give occipital nerve blocks and prescribe short courses of prednisone (corticosteroid). If headaches persist, a blood pressure medication, verapamil can be effective if given in high doses. The new migraine drugs, CGRP monoclonal antibodies (Aimovig, Ajovy, and Emgality), appear to be very effective for some patients with cluster headaches, although they are not yet FDA-approved for this type of headaches.

Written by
Alexander Mauskop, MD
Continue reading
May 21, 2026
Research
Your Brain Has Many Pathways, And TMS Can Now Use Them
A groundbreaking University of Iowa study shows that personalized fMRI-guided TMS can now reach and modulate the deep hippocampus — the brain’s command center for memory, emotion, and migraine — without surgery or heavy medications. By mapping each patient’s unique neural pathways, TMS delivers precise stimulation to surface “control points” that influence deep brain structures. Generic approaches barely work, but individualized targeting produces clear, measurable changes. At our headache clinic, we combine TMS and fMRI to offer this advanced, personalized treatment for migraines, depression, PTSD, anxiety, and more.
Read article
May 10, 2026
Research
Elismetrep: A Promising New Experimental Migraine Treatment
Elismetrep is a promising experimental migraine medication that targets the TRPM8 pathway rather than serotonin or CGRP. Early clinical trials suggest it may offer a new option for patients who do not respond well to current treatments.
Read article
May 6, 2026
Alternative Therapies
New Research on Brain Excitability and TMS Treatment for Migraine
New research shows how the brain dynamically regulates excitability in real time—and why this matters for transcranial magnetic stimulation (TMS) as a treatment for migraine.
Read article
Insights from Dr. Alexander Mauskop on headaches and migraines
Subscribe to the Blog.
Subscribe
Subscribe